PROCEPT BioRobotics Corporation - Laporan Laba Rugi (TTM)

PROCEPT BioRobotics Corporation
US ˙ NasdaqGM ˙ US74276L1052

Laporan Laba Rugi (TTM)

Laporan Laba Rugi PROCEPT BioRobotics Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 8 14 21 28 34 41 50 61 75 85 102 116 136 156 177 200 224 249 275
Change (%) 77.72 53.09 31.24 25.10 20.32 19.81 23.51 22.22 13.61 19.26 14.52 17.02 14.78 12.95 13.18 12.34 10.97 10.37
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 9 11 13 16 19 21 25 30 38 43 50 56 65 73 80 85 87 93 98
Change (%) 18.10 26.92 17.02 18.24 15.26 15.44 22.98 24.56 14.26 14.93 12.27 16.50 11.65 9.89 6.54 2.63 6.29 5.99
% of Revenue 116.26 77.26 64.05 57.11 53.98 51.71 49.83 49.61 50.56 50.85 49.01 48.04 47.83 46.53 45.27 42.61 38.93 37.29 35.81
Gross Operating Profit -1 3 8 12 16 20 25 31 37 42 52 60 71 84 97 115 137 156 176
Change (%) -348.49 142.04 56.58 34.23 26.25 24.48 24.03 19.92 12.94 23.74 16.68 17.49 17.65 15.62 18.66 19.55 13.95 12.97
% of Revenue -16.26 22.74 35.95 42.89 46.02 48.29 50.17 50.39 49.44 49.15 50.99 51.96 52.17 53.47 54.73 57.39 61.07 62.71 64.19
SG&A 30 34 39 44 51 59 66 79 89 101 113 121 132 141 150 159 171 187 203
Change (%) 10.92 15.66 13.04 16.26 15.75 12.45 19.02 12.35 13.22 12.72 7.17 8.46 7.19 5.92 6.56 7.53 9.10 8.28
% of Revenue 392.28 244.84 184.97 159.31 148.05 142.42 133.68 128.82 118.42 118.02 111.54 104.39 96.76 90.35 84.73 79.77 76.35 75.07 73.65
R&D 16 17 17 18 19 19 22 24 29 35 40 44 48 51 57 62 62 66 66
Change (%) 3.70 3.30 5.89 2.89 2.57 11.45 12.27 18.90 19.76 14.14 10.14 11.03 4.84 11.59 8.90 0.92 5.33 0.20
% of Revenue 210.90 123.06 83.03 66.99 55.10 46.97 43.69 39.71 38.63 40.73 38.98 37.49 35.57 32.49 32.10 30.89 27.75 26.34 23.91
OpEx 56 61 70 78 89 100 113 134 156 179 203 221 245 265 286 306 321 346 367
Change (%) 9.97 14.19 12.02 13.50 12.82 12.90 18.59 16.32 14.69 13.53 9.00 11.00 7.91 8.10 7.02 4.83 7.60 6.13
% of Revenue 719.44 445.17 332.05 283.41 257.12 241.10 227.19 218.15 207.61 209.59 199.52 189.92 180.16 169.37 162.09 153.27 143.04 138.70 133.37
Operating Income -48 -47 -49 -51 -54 -59 -63 -73 -81 -93 -101 -105 -109 -108 -110 -106 -97 -96 -92
Change (%) -0.97 2.92 3.73 7.17 8.05 8.00 14.73 11.32 15.70 8.30 3.46 4.32 -0.67 1.11 -2.90 -9.25 -0.22 -4.81
% of Revenue -619.44 -345.17 -232.05 -183.41 -157.12 -141.10 -127.19 -118.15 -107.61 -109.59 -99.52 -89.92 -80.16 -69.37 -62.09 -53.27 -43.04 -38.70 -33.37
Interest Expense -5 -6 -6 -6 -6 -6 -6 -6 -5 -5 -4 -4 -4 -4 -4 -4 -4 -4 -4
Change (%) 7.84 6.78 1.37 -5.39 -0.74 0.09 -0.26 -9.97 -10.32 -10.24 -10.45 6.93 3.98 1.56 2.87 -3.59 -4.02 -3.34
% of Revenue -68.17 -41.37 -28.85 -22.29 -16.85 -13.90 -11.62 -9.38 -6.91 -5.45 -4.10 -3.21 -2.93 -2.66 -2.39 -2.17 -1.86 -1.61 -1.41
Net Income -53 -53 -55 -57 -60 -64 -69 -77 -87 -98 -105 -107 -106 -103 -104 -100 -91 -90 -84
Change (%) -0.08 3.24 3.83 5.41 7.29 7.17 12.37 12.70 12.96 6.20 1.92 -0.63 -2.39 0.33 -3.52 -8.64 -1.33 -6.70
% of Revenue -687.04 -386.27 -260.47 -206.06 -173.62 -154.82 -138.49 -126.00 -116.18 -115.53 -102.88 -91.56 -77.76 -66.12 -58.73 -50.07 -40.72 -36.20 -30.60

Source: Capital IQ

Other Listings
MX:PRCT
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista